Supreme Court hears case on banning treatments for transgender minors
The Supreme Court case centers on Tennessee’s ban on puberty blockers and hormone treatments, which trans patients call lifesaving and the state made illegal.
By Casey Parks and Ann E. MarimowPuberty blockers, hormones: What to know about gender care for minors
Frequently asked questions about gender transition care for minors, including what are puberty blockers and whether cross-sex hormones impact fertility.
By Casey ParksNo more daylight saving time? Musk, Ramaswamy muse on ending clock changes.
The “Department of Government Efficiency” may target the century-old practice, the men suggested on social media. It was not immediately clear whether they were serious.
By Dan DiamondSupreme Court appears sympathetic to FDA’s rejection of flavored vapes
The FDA has rejected applications for more than 1 million fruit-, candy- and dessert-flavored e-cigarettes and vaping liquids in recent years.
By Justin Jouvenal and Rachel RoubeinConsider these tools to help you remember when to take pills
Poor medication adherence results in 125,000 deaths each year. So it’s crucial to have a system that keeps you on track.
By Alexandra FrostHow a Supreme Court case on vaping could affect the FDA
A ruling against the FDA could upend how the agency considers applications for new tobacco products.
By David Ovalle and McKenzie BeardPotential conflicts of interest may haunt Dr. Oz’s confirmation to run Medicare, Medicaid
Dr. Oz has extolled Ozempic’s promise for weight-loss. Now Medicare, which Trump wants Oz to oversee, may cover it.
By Desmond Butler, Lauren Weber and Caitlin GilbertWith more active lifestyle, average adult could live 5.3 years longer
The least active Americans appear to have the most to gain.
By Ian McMahanSupreme Court poised to enter fray over regulation of flavored vapes
The Food and Drug Administration has rejected some products because of concerns about youth users.
By David Ovalle and Rachel RoubeinHow to take advantage of Medicare’s expanded drug benefit in 2025
It will be easier to spread out Part D drug costs over the year, while the total annual cost of medicines will be capped at $2,000.
By Kerry Dooley YoungA winning mix: High standards, high support
“Positive discomfort” is the idea that full potential lies on the other side of being challenged. But it’s also a leap beyond “no pain, no gain.”
By Alexandra MoeWhy one expert says it’s time to redefine cerebral palsy
Focusing on early detection and prevention has skewed awareness of the permanent nature of the disability, a health expert writes.
By Erin BlakemoreTrump’s former FDA commissioner warns RFK Jr. could ‘cost lives’ if confirmed
Scott Gottlieb said he’s worried that Trump’s pick to run HHS, Robert F. Kennedy Jr., will follow through on past antivaccine rhetoric.
By Dan DiamondU.K. backs assisted-dying law after emotional debate over end-of-life care
The bill, modeled after Oregon’s law, would apply to terminally ill patients and could usher in one of the most dramatic social changes Britain has seen in years.
By Karla AdamHow music can change your perceptions of a memory
Listening to music can change how you feel about what you remember — potentially offering new ways to help people cope with difficult memories.
By Yiren RenHIV prevention pills should be free, but insurers are still charging
Insurance companies have to pay for PrEP under federal rules, but some skirt the requirement for free access to the treatment critical to preventing HIV.
By Fenit NirappilBiden officials end fight over $6.6B contract that became election-year battle
HHS had moved to rebid the pricey 1-800-MEDICARE call center contract but attached new labor-friendly provisions. GOP leaders called it a favor to unions.
By Dan DiamondTrump picks Jay Bhattacharya to lead NIH, overseeing scientific research
The president-elect also named Jim O’Neill, a Silicon Valley investor and former federal health official, to be deputy secretary of Health and Human Services.
By Dan DiamondYour next hospital stay could involve fewer IV fluid bags. Here’s why.
Today’s newsletter: Hospitals find lasting workarounds on IV fluid shortages. Pandemic response critic named to lead NIH, and more.
By Jackie Fortiér and McKenzie BeardU.S. okays organ transplants between people with HIV, expanding donor pool
The landmark move is expected to shorten wait times for organs for all patients and reduce hurdles to life-saving care for those with HIV.
By Anumita Kaur